慢性骨髓增殖性瘤的突变概况:改善临床分子预后模型
Giuseppe G Loscocco1,2, Naseema Gangat2, Paola Guglielmelli1
1Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
Expert review of molecular diagnostics
|October 11, 2025
概括
骨髓增殖性瘤 (MPN) 是由JAK2,CALR或MPL等突变驱动的克隆性造血性疾病. 了解分子景观有助于对MPN患者进行风险分层和个性化治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 经典的骨髓增殖性瘤 (MPN),包括真多细胞血症 (PV),基本血栓细胞血症 (ET) 和骨髓纤维化 (MF),是克隆性造血性疾病.
- 这些疾病的特点是成熟的造血细胞异常增殖,并且经常与JAK2,CALR或MPL基因的突变有关.
- 这些突变导致JAK-STAT信号通路的构成性激活,这是MPN病变发生的关键机制. 与染色体修饰,DNA甲基化和转录调节相关的基因的额外突变很常见,特别是在MF中.
研究的目的:
- 审查MPN的分子格局,包括驱动和非驱动突变.
- 检查分子分析对患者管理的影响,包括诊断,监测和治疗反应.
- 评估基于人工智能的预后模型在MPN中的潜力.
主要方法:
- 高通量基因组特征的MPN识别驱动和非驱动突变.
- 将突变概况与细胞遗传学,组织病理学和临床数据进行整合,以进行风险分层.
- 审查新兴的人工智能模型用于MPN的预后评估.
主要成果:
- 临床相关的驱动突变 (JAK2,CALR,MPL) 对于MPN诊断和管理至关重要.
- 突变档案与其他临床数据相结合,有助于根据血栓形成风险,存活率和白血病进展情况对患者进行分类.
- 目前正在进行的研究重点是开发二次髓纤维化增强的评分系统,并确定预测特定结果的共变模式.
结论:
- 分子特征是个性化MPN管理和治疗策略的基础.
- 基于分子和临床数据的准确风险分层可以改善患者的治疗结果.
- 人工智能有望提高MPN的预后准确性,尽管需要进一步评估.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.6K
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.8K
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...